Chemical Compound

Fluticasone Dimer Impurity

CAS Registry Number 220589-37-7
Back to search Request a Quote
Fluticasone Dimer Impurity chemical structure
Primary Record

Fluticasone Dimer Impurity

In stock
4,480 g
Purity
98.7 %
CAS
220589-37-7

Compound Identifiers & Properties

CAS
220589-37-7
PubChem CID
71316902
SMILES
C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)O[C@@]5([C@@H](C[C@@H]6[C@@]5(C[C@@H]([C@]7([C@H]6C[C@@H](C8=CC(=O)C=C[C@@]87C)F)F)O)C)C)C(=O)SCF)O)C)O)F)C)F
Canonical SMILES
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

Names & Synonyms

  • Fluticasone Dimer Impurity
  • 220589-37-7
  • UNII-1V165RFB9Y
  • 1V165RFB9Y
  • RefChem:199133
  • Fluticasone EP Impurity G
  • orb1983157
  • Fluticasone Propionate EP Impurity G
  • AMY38977
  • ARD193851
  • Fluticasone Dimer Impurity (~90%)
  • Fluticasone Dimer Impurity (Impurity G)
  • DA-63498
  • FLUTICASONE PROPIONATE RELATED COMPOUND E
  • HY-141410
  • CS-0168715
  • FT-0668769
  • J1.052.786D
  • G91047
  • FLUTICASONE PROPIONATE IMPURITY G [EP IMPURITY]
  • [(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylate
  • 6alpha,9-Difluoro-17-(((fluoromethyl)sulfanyl)carbonyl)-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylate
  • FLUTICASONE PROPIONATE IMPURITY G (EP IMPURITY)
  • Q27252926
  • FLUTICASONE PROPIONATE RELATED COMPOUND E [USP IMPURITY]
  • FLUTICASONE PROPIONATE RELATED COMPOUND E (USP IMPURITY)
  • Fluticasone Propionate EP Impurity G; Fluticasone Furoate Impurity K
  • (1R,2R,3aS,3bS,5S,9aS,9bR,10S,11aS)-5,9b-difluoro-1-{[(fluoromethyl)sulfanyl]carbonyl}-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl (1R,2R,3aS,3bS,5S,9aS,9bR,10S,11aS)-5,9b-difluoro-1,10-dihydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1-carboxylate
  • (6|_,11|_,16|_,17|_)-6,9-Difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl (6|_,11|_,16|_,17|_)-6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
  • (6|A,11|A,16|A,17|A)-6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxo-Androsta-1,4-diene-17-carboxylic Acid (6|A,11|A,16|A,17|A)-6,9-difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl Ester
  • (6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl (6alpha,11beta,16alpha,17alpha)-6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
  • (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate
  • 6.ALPHA.,9-DIFLUORO-17-(((FLUOROMETHYL)SULFANYL)CARBONYL)-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIEN-17.ALPHA.-YL 6.ALPHA.,9-DIFLUORO-11.BETA.,17-DIHYDROXY-16.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIENE-17.BETA.-CARBOXYLATE
  • 6alpha,9-Difluoro-16alpha-methyl-11beta-hydroxy-17-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylic acid 6alpha,9-difluoro-16alpha-methyl-11beta-hydroxy-17-[(fluoromethylthio)carbonyl]-3-oxoandrosta-1,4-diene-17alpha-yl ester
  • 6alpha,9-Difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylate
  • Androsta-1,4-diene-17-carboxylic acid, 6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxo-, (6alpha,11beta,16alpha,17alpha)-6,9-difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl ester, (6alpha,11beta,16alpha,17alpha)-
  • Androsta-1,4-diene-17-carboxylic acid, 6,9-difluoro-11,17-dihydroxy-16-methyl-3-oxo-, (6alpha,11beta,16alpha,17alpha)-6,9-difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl ester, (6alpha,11beta,16alpha,17alpha)-; 6alpha,9-Difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl 6alpha,9-Difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylate; Fluticasone Propionate Imp. G (EP); GR 112801X; BP Fluticasone Propionate Impurity G; Ph Eur Fluticasone Propionate Impurity G; USP Fluticasone Propionate Related Compound E; CAF (GW694301X); GW 872664X; TAF (GW675713X); 6-des-fluoro 698 (GW836850X); GSK465433A and GSK1322631A; 5-chloro-furoyl 698 (GSK180878A); TA-TAF dimer (GW871519X); Compound A (fluticasone propionate related); unidentified impurity with RRT 1.23; disulp